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Fenthion [O,O-dimethyl-O-(4-methylmer-
capto)-3-methylphenylthio-phosphate] is an
organophosphorus pesticide widely used
throughout the world as a broad-spectrum
insecticide for numerous crops and also as an
ectoparasiticide for farm animals (Roberts and
Hutson 1999). Fenthion inhibits acetylcholine
esterase and is thought to be a safe pesticide
because it is not easily converted to the possibly
highly toxic oxon derivative in animal species.
However, toxic effects such as ultrastructural
change in testes of gobiid ﬁsh, reduction in lar-
val production in sand ﬁddler crabs, chronic
toxicity in hens, acute toxicity in birds, reptiles,
and ﬁsh, and decreases in muscarinic receptor
function in rat retina have been reported
(Mullie et al. 1999; Schoor et al. 2000; Tandon
et al. 1994; Tuler and Bowen 1999; Zutshi and
Murthy 2001). Furthermore, it has been
reported that fenthion and its oxidation prod-
ucts, fenthion sulfoxide and fenthion oxon,
contaminate olives, mosquitos, fish, and the
environment (Cavanna and Molinari 1998;
Fukushima 1991; Kitamura et al. 2000;
Lacorte et al. 1997; Meyer et al. 1998; Peiris
and Hemingway 1996; Pereira and Hostettler
1993; Prasad et al. 1997; Tsuda et al. 1996).
The relationship between the toxicity and
metabolism of fenthion has been examined in
human neuroblastoma cell lines, birds, and ﬁsh,
and either an increase or a decrease in toxicity
as a result of metabolism was found (Cova et al.
1995; Kitamura et al. 2000; Roux et al. 1995).
Many environmental xenobiotics exert
hormonal effects at the cellular and organismal
levels. These compounds can mimic the 
biologic activity of sex hormones and thyroid
hormone and are called “endocrine-disrupting
chemicals.” The estrogenic chemicals include
chlorinated insecticides such as kepone, o,p´-
DDT, dieldrin, methoxychlor, and nonchlori-
nated compounds used in the plastics and
detergent industries, such as alkylphenols and
bisphenol A (Andersen et al. 1999; Gaido 
et al. 1997; Soto et al. 1994). We demon-
strated that fenthion does not have estrogenic
activity, based on the ﬁnding that vitellogenin
levels in male goldfish were not enhanced
when the ﬁsh were kept in fenthion solution
(Kitamura et al. 1999). However, the estro-
genic activity of fenthion has not been exam-
ined in mammalian cell lines. Further, the
antiandrogenic activity of fenthion has not
been examined, even though some pesticides
are known to have antiandrogenic properties.
The pesticide vinclozolin is known to exhibit
antiandrogenic activity after metabolic activa-
tion (Gray et al. 1994; Kelce et al. 1994).
Flutamide, a diuretic agent, must also be
metabolically activated before it can exert
effects (Wong et al. 1995). The widespread
use of these pesticides and fungicides in the
environment may generate antiandrogens by
metabolic activation and may alter male sexual
development and reproductive processes
(Kelce and Wilson 1997).
To clarify the endocrine-disrupting action
of fenthion and related compounds, we exam-
ined their androgenic and antiandrogenic activ-
ities in this study using androgen-responsive
element (ARE)-luciferase reporter-transfected
mouse ﬁbroblast cell line NIH3T3 in vitro and
the Hershberger assay in vivo. We also exam-
ined the estrogenic and antiestrogenic activities
using estrogen-responsive element (ERE)-
luciferase reporter-transfected human breast
cancer cell line MCF-7. The inﬂuence of the
metabolism of fenthion on these endocrine-
disrupting activities was investigated using rat
liver preparations.
Materials and Methods
Chemicals. Fenthion (98% pure), fenthion
sulfoxide (99%), fenthion sulfone (99%),
fensulfothion (98%), fenitrothion (98%),
trichlorfon (98%), malathion (99%), and
EPN (ethyl p-nitrophenyl benzenethiophos-
phonate, 98%) were purchased from Wako
Pure Chemical Industries, Ltd. (Osaka,
Japan). Dihydrotestosterone (DHT), 2-
hydroxypyrimidine, and menadione were
obtained from Tokyo Chemical Industry Co.,
Ltd. (Tokyo, Japan). SKF 525-A, α-naph-
thoﬂavone, 17β-estradiol (E2), and α-naphthyl-
thiourea were purchased from Sigma
Chemical Co. (St. Louis, MO, USA).
Animals. Male rats were housed at 22°C
with a 12-hr light/dark cycle, with free access
to tap water and a standard pellet diet MM-3
(Funabashi Farm, Funabashi, Japan). All
experiments were conducted in accordance
with the Guide for the Care and Use of
Laboratory Animals of Hiroshima University.
Cell culture. NIH3T3 and MCF-7 cells
were maintained in Dulbecco’s Modified
Eagle’s Medium (DMEM) (Sigma) plus 5%
calf serum (Gibco/Invitrogen Corp., Carlsbad,
CA, USA) and DMEM plus 5% fetal bovine
serum (Gibco/Invitrogen), respectively, con-
taining penicillin and streptomycin. For
assays, the medium was changed to phenol
red-free DMEM (Sigma) containing the same
antibiotics along with dextran-charcoal-treated
calf serum or fetal bovine serum for a week.
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We investigated the endocrine-disrupting actions of the organophosphorus pesticide fenthion and
related compounds and the inﬂuence of metabolic transformation on the activities of these com-
pounds. Fenthion acted as an antagonist of the androgenic activity of dihydrotestosterone (10–7 M) in
the concentration range of 10–6–10–4 M in an androgen-responsive element–luciferase reporter-
responsive assay using NIH3T3 cells. The antiandrogenic activity of fenthion was similar in magni-
tude to that of ﬂutamide. Fenthion also tested positive in the Hershberger assay using castrated male
rats. Marked estrogenic and antiestrogenic activities of fenthion and related compounds were not
observed in MCF-7 cells. When fenthion was incubated with rat liver microsomes in the presence of
NADPH, the antiandrogenic activity markedly decreased, and fenthion sulfoxide was detected as a
major metabolite. The oxidase activity toward fenthion was exhibited by cytochrome P450 and ﬂavin-
containing monooxygenase. Fenthion sulfoxide was negative in the screening test for antiandrogens,
as was fenthion sulfone. However, when fenthion sulfoxide was incubated with liver cytosol in the
presence of 2-hydroxypyrimidine, an electron donor of aldehyde oxidase, the extract of the incubation
mixture exhibited antiandrogenic activity. In this case, fenthion was detected as a major metabolite of
the sulfoxide. Metabolic interconversion between fenthion and fenthion sulfoxide in the body seems
to maintain the antiandrogenic activity. Key words: aldehyde oxidase, antiandrogenic activity,
cytochrome P450, endocrine disruption, fenthion, fenthion sulfoxide. Environ Health Perspect
111:503–508 (2003). doi:10.1289/ehp.5917 available via http://dx.doi.org/ [Online 15 January 2003]
Research | ArticlesPlasmids. The p(ARE)2-luc plasmid was
constructed with pGL3-enhancer (Promega
Co., Madison, WI, USA) by inserting a syn-
thetic double-strand oligo-DNA containing
the consensus androgen-responsive element
5´-CATAGTACGTGATGTTCTAGGCC-
TAGTACGTGATGTTCTCTATAC (with
Sac I/Xho I ends). For pSG5-hAR, human
androgen receptor cDNA was ampliﬁed from
human prostate cDNA by polymerase chain
reaction with LA-Taq (Takara) and intro-
duced into pCR2.1 with a TA Cloning Kit
(Invitrogen). The EcoRI fragment was then
inserted into the EcoRI site in the pSG5 plas-
mid. The p(ERE)3-SV40-luc plasmid, which
contains three tandem copies of the consen-
sus ERE, was a gift from M. Kudoh of
Yamanouchi Pharmaceutical Co. (Tsukuba,
Japan). pRL-CMV Renilla luciferase derived
with the CMV enhancer/promoter (Promega
Co., Madison, WI, USA) was used as the
internal control.
Liver preparations. Male rats (160–190 g,
Slc:Wistar/ST strain) obtained from Japan
SLC, Inc. (Shizuoka, Japan) were used. Livers
were excised from exsanguinated rats and
immediately perfused with 1.15% KCl. The
livers were homogenized in 4 volumes of
1.15% KCl. The homogenate was centrifuged
for 20 min at 9,000 × g. We further separated
the supernatant fraction into cytosol and
microsomes by centrifugation for 60 min at
105,000 × g. The microsomes were washed
by resuspension in 2 volumes of the KCl solu-
tion and resedimentation for 60 min at
105,000 × g. The washed microsomes were
suspended in a volume of 1.15% KCl equiva-
lent to the original liver weight. The microso-
mal fraction was stored at –80°C before use.
Puriﬁcation of aldehyde oxidase from livers
of rats. We puriﬁed aldehyde oxidase from rat
livers according to the reported method
(Sugihara et al. 1995). The cytosol obtained
from 14 g of rat liver was used for the puriﬁca-
tion. The active fractions showed a single band
on sodium dodecyl sulfate-polyacrylamide gel
electrophoresis.
Assay of androgenic and antiandrogenic
activities in vitro. We measured androgenic
activity using the ARE-luciferase reporter assay
in NIH3T3 cells. Cells were plated at 5 ×
104/well in 24-well plates and transiently
transfected with 0.1 µg of pSG5-hAR, 0.5 µg
of p(ARE)2-luc with TransFast transfection
reagent containing a synthetic cationic lipid
(Promega), following the supplied protocol.
The weight ratio of TransFast reagent to
DNA was 1:1. After 24-hr incubation with
samples, cells were harvested with 50 µL of
cell lysis buffer (Promega) and the ﬁreﬂy and
renilla luciferase activities were determined
with the dual luciferase assay kit (Promega) by
measuring luminescence with a Wallac Micro-
Beta scintillation counter (PerkinElmer Life
Sciences, Boston, MA, USA). Fireﬂy luciferase
reporter activity was normalized to renilla
luciferase activity from pRL-CMV. To assess
antiandrogenic activity, the inhibitory effects
of test compounds on the androgenic activity
of DHT at the concentrations of 10–11 and
10–10 M was examined. Because androgen,
progesterone, and glucocorticoid receptors
share the same hormone-responsive element,
the reporter responses to progesterone and
glucocorticoid were examined and conﬁrmed
to be negative (data not shown). Data are
expressed as the means ± SD of four experi-
ments using independent transfected cells.
In the assay of the antiandrogenic activity
of the metabolites produced from fenthion or
fenthion sulfoxide, substrates (0.1 µmol) were
incubated with 0.1 mL rat liver microsomes
in the presence of 1 µmol of NADPH, or
with 0.2 mL liver cytosol in the presence of
2-hydroxypyrimidine for 30 min in a final
volume of 1 mL 0.1 M phosphate buffer.
After the incubation, the mixture was
extracted with 5 mL ethyl acetate and evapo-
rated to dryness. The residue was dissolved in
1 mL ethanol, and an aliquot was used for the
antiandrogenic activity assay described above.
We calculated the total concentration of the
substrate and its metabolites from the original
amount of the substrate.
Assay of androgenic and antiandrogenic
activities in vivo (Hershberger assay). We used
F344 male rats obtained from Charles River
Co. (Kanagawa, Japan). They were surgically
castrated at 5 weeks of age. At 7 weeks of age,
they were divided into ﬁve groups consisting
of seven animals each, except six in the con-
trol. We treated the rats once a day for 7 days
with subcutaneous doses of 0.2 mL of vehicle
(Panacete 810; Nippon Oils and Fats Co.,
Ltd., Tokyo, Japan), testosterone propionate
(500 µg/kg/day), testosterone propionate
plus ﬂutamide (6 mg/kg/day), or testosterone
plus fenthion (25 or 50 mg/kg/day). We sac-
riﬁced animals under anesthesia and dissected
and weighed the ventral prostate and seminal
vesicles.
Assay of estrogenic and antiestrogenic
activities in vitro. We assayed estrogenic
activity according to the previously reported
method using an ERE-luciferase reporter in
MCF-7 cells (Sugihara et al. 2000). Briefly,
transient transfections in MCF-7 cells were
performed using TransFast in 12-well plates
at 1 × 105 cells/well with 1.9 µg p(ERE)3-
SV40-luc and 0.1 µg pRL-CMV as an inter-
nal standard. Twenty-four hours after
addition of the sample, the assay was per-
formed with a dual luciferase assay kit. We
measured antiestrogenic activity in terms of
the inhibitory effect of the test compounds
on the estrogenic activity of E2 at the concen-
trations of 1 × 10–10 and 1 × 10–9 M. Data
are expressed as the means ± SD of four
experiments using independent transfected
cells.
Metabolizing activities of rat liver 
preparations. The incubation mixture con-
sisted of 0.2 µmol fenthion or fenthion sulfox-
ide, 1 µmol of an electron donor and liver
microsomes (2–3 mg protein) or cytosol (1–2
mg protein) in a ﬁnal volume of 1 mL of 0.1
M K,Na-phosphate buffer (pH 7.4). The
incubation was continued for 30 min at 37°C.
In the case of reduction of fenthion sulfoxide,
the incubation was performed using a
Thunberg tube under anaerobic conditions.
The side arm contained an electron donor,
and the body contained all other components.
The tube was gassed for 3 min with nitrogen,
evacuated with an aspirator for 5 min, and
again gassed with nitrogen. The reaction was
started by mixing the components of the side
arm and the body together. After the incuba-
tion, the mixture, after addition of 10 nmol
benzophenone as an internal standard and two
volumes of acetonitrile, was centrifuged, and
an aliquot of the supernatant was subjected to
analysis by high-performance liquid chro-
matography (HPLC). The time-course of the
formation of the metabolite in the presence of
NADPH with 1.5 mg protein of liver micro-
somes of rats was linear to 60 min. The
dependency on amount of liver microsomes
was linear up to 10 mg protein. Data are
expressed as the means ± SD of four experi-
ments using independent rats.
HPLC. HPLC was performed in a Hitachi
L-7110 high-performance liquid chromato-
graph (Tokyo, Japan) equipped with an ultravi-
olet absorption detector. The instrument was
ﬁtted with a 4 × 125 mm Inertsil ODS-3 col-
umn (GL-Science, Tokyo, Japan). The mobile
phase was acetonitrile–0.1 M KH2PO4 (6:4,
vol/vol, pH 5.4). The chromatograph was oper-
ated at a flow rate of 0.5 mL/min and at a
wavelength of 254 nm. Elution times of fen-
thion sulfoxide, fenthion sulfone, benzo-
phenone, and fenthion were 5.8, 8.8, 15.2, and
25.4 min, respectively. We determined the
amounts of metabolites formed from the peak
areas. In some experiments for the determina-
tion of metabolites, a Beckman 168 photodiode
array ultraviolet (UV) detector (Beckman
Instruments, Inc., Fullerton, CA, USA) was ﬁt-
ted to the HPLC unit to identify the metabo-
lites of fenthion and fenthion sulfoxide.
GC-MS. Gas chromatography–mass spec-
trometry (GC-MS) was performed using a
Shimadzu GC-17A/QP-5000 (Kyoto, Japan)
in the electron impact mode. A DB-5 fused-
silica capillary column (30 m × 0.25 mm i.d.;
J & W Scientiﬁc Inc., Folsom, CA, USA) was
used. The column temperature was held at
100°C for 5 min, then increased at a rate of
10°C/min to 200°C. We injected 1 µL of
sample into the injection port at 220°C.
Splitless injection was used. The retention
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12.2 and 14.7 min, respectively.
Results
Androgenic and antiandrogenic activities of
fenthion and metabolites. Androgenic and
antiandrogenic activities of fenthion, fen-
thion sulfoxide, and fenthion sulfone were
examined using an ARE-luciferase reporter in
NIH3T3 cells. These compounds had no
detectable androgenic activity in the concen-
tration range of 10–7–10–4 M. In contrast,
DHT at 10–11–10–9 M exhibited marked
androgenic activity (Figure 1A). When fen-
thion was added to the assay system at
10–7–10–5 M, the activity of DHT at a con-
centration of 10–11 M was inhibited concen-
tration dependently. This antiandrogenic
effect of fenthion was also observed at a con-
centration of 10–10 M DHT. The antiandro-
genic activity of fenthion is comparable to
that of ﬂutamide. However, fenthion sulfox-
ide and fenthion sulfone did not show such
antiandrogenic effects in the concentration
range of 10–7–10–5 M (Figure 1B,C).
Antiandrogenic activities of fenthion-
related compounds. Antiandrogenic activities
of fenthion and related compounds were
comparatively examined with an ARE-
luciferase reporter in NIH3T3 cells. Figure 2
shows the IC50 (concentration for 50% inhi-
bition) values of fenthion, fenthion sulfoxide,
fenthione sulfone, fenitrothion, fensulfothion,
EPN, trichlorfon, and malathion against the
androgenic activity of DHT at a concentra-
tion of 10–10 M. The highest activity among
organophosphorus compounds was observed
in fenitrothion, followed by fenthion and
EPN. However, fenthion sulfoxide, fenthion
sulfone, fensulfothion, trichlorfon, and
malathion did not show such activity. These
results indicate that some organophosphorus
insecticides have antiandrogenic but not
androgenic activity.
Estrogenic and antiestrogenic activities of
fenthion and metabolites. Estrogenic activities
of fenthion, fenthion sulfoxide, and fenthion
sulfone were examined using ERE-luciferase
reporter-transfected MCF-7 cells. E2 exhibited
estrogenic activity at 10–12–10–9 M. In contrast,
no estrogenic activity of fenthion, fenthion sul-
foxide, or fenthion sulfone was observed in the
concentration range of 10–7–10–4 M, except for
a marginal effect at 10–4 M (data not shown).
When fenthion, fenthion sulfoxide, or fenthion
sulfone was added to the assay system of E2 in
the concentration range of 10–8–10–5 M, the
estrogenic activity of E2 at the concentrations of
10–11 M and 10–10 M was not inhibited (data
not shown). Thus, no signiﬁcant estrogenic or
antiestrogenic effect of fenthion and related
compounds was observed.
Antiandrogenic activity of fenthion after
metabolism with rat liver microsomes. The
effect of the metabolism of fenthion by rat
liver microsomes on the antiandrogenic activ-
ity of the compound was examined. When
fenthion was incubated with rat liver micro-
somes in the presence of NADPH, the
inhibitory effect of the extract on the andro-
genic activity of DHT at the concentrations
of 10–11 and 10–10 M was markedly decreased
compared with the original activity of fen-
thion. The decrease of antiandrogenic activity
was minimal when the incubation was per-
formed without liver microsomes (Figure
3A,B). Fenthion sulfoxide was detected by
HPLC as a major metabolite in the complete
incubation mixture. The mass and UV spec-
tra of the metabolite confirmed that it was
fenthion sulfoxide (data not shown).
Articles | Antiandrogenic activity of fenthion
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sulfoxide after metabolism with rat liver
cytosol. When fenthion sulfoxide was incu-
bated with rat liver cytosol in the presence of
2-hydroxypyrimidine, an electron donor of
aldehyde oxidase, under anaerobic conditions,
the extract of the incubation mixture inhibited
the androgenic activity of DHT on NIH3T3
cells in the range of 10–7–10–5 M. The anti-
androgenic activity was not observed after
incubation without liver cytosol (Figure 3C,
D). Such metabolic activation did not occur
after the incubation of fenthion sulfoxide with
liver microsomes in the presence of NADPH.
When fenthion sulfoxide was incubated with
liver cytosol of rats in the presence of 2-
hydroxypyrimidine, one metabolite, of which
the retention time corresponded to that of fen-
thion, was detected in HPLC of the extract.
The metabolite was identiﬁed by comparison
of the mass and UV spectra with those of
authentic fenthion, as described in “Materials
and Methods.” Fenthion was not detected in
HPLC of the incubation mixture of fenthion
sulfoxide with rat liver microsomes (data not
shown). These results suggest that the oxida-
tion of fenthion acts as a detoxiﬁcation path-
way and the reduction of fenthion sulfoxide to
fenthion as an activation step, and this inter-
conversion between fenthion and fenthion sul-
foxide in the body functions to maintain the
antiandrogenic activity of fenthion.
Metabolism of fenthion and fenthion 
sulfoxide by rat liver preparations. In the con-
version of fenthion to fenthion sulfoxide by
rat liver microsomes, NADPH was effective
as an electron donor. The NADPH-linked
oxidizing activity in liver microsomes of rats
toward fenthion was signiﬁcantly inhibited by
α-naphthylthiourea and partially inhibited by
SKF 525-A, α-naphthoﬂavone, and quinidine
(Figure 4A). This suggests that the oxidizing
activity to the sulfoxide is due to both
cytochromes P450 (CYPs) and ﬂavin-contain-
ing monooxygenase (FMO) in the rats.
Fenthion was formed from fenthion 
sulfoxide by rat liver cytosol when 2-hydroxy-
pyrimidine or benzaldehyde, which are electron
donors of aldehyde oxidase, was added under
anaerobic conditions. However, xanthine, an
electron donor of xanthine oxidase, was not
effective for the reduction. In the cytosolic
reduction, NADPH and NADH were also
much less effective than 2-hydroxypyrimidine.
The 2-hydroxypyrimidine-dependent activity
in rat liver was inhibited by menadione, which
is an inhibitor of aldehyde oxidase, but not by
oxypurinol, an inhibitor of xanthine oxidase
(Figure 4B). This suggests that the reducing
activity is due to aldehyde oxidase in rat liver
cytosol. Indeed, puriﬁed aldehyde oxidase from
rats exhibited a signiﬁcant sulfoxide reductase
activity (64.7 nmol/min/mg protein) in the
presence of 2-hydroxypyrimidine. In contrast,
liver microsomes exhibited no reductase activity
even in the presence of NADPH, indicating
that CYP was not involved in the fenthion sul-
foxide reduction (data not shown). The cytoso-
lic reductase activity toward fenthion sulfoxide
was higher than the NADPH-dependent
microsomal oxidase activity toward fenthion.
Hershberger assay of fenthion. Anti-
androgenic potential of fenthion in vivo
was further investigated by means of the
Hershberger assay using Fischer 344 rats
according to the Hershberger protocol
(Hershberger et al. 1953). Body weight was
decreased by 25% in the group administered
the higher dose of fenthion, but there were no
significant differences among other groups.
Teststerone treatment significantly increased
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Figure 3. Antiandrogenic activity of fenthion (A,B) and fenthion sulfoxide (C,D) after incubation with rat
liver microsomes or cytosol. Abbreviations: Ms, microsomes; Cs, cytosol. Antiandrogenic activity was
examined with the ARE-luciferase reporter system in the presence of DHT at the concentrations of 10–11 M
(A,C) and 10–10 M (B,D). The data indicate percent values of the ARE-luciferase activity to the level induced
by DHT. In A and B, fenthion was incubated with rat liver microsomes in the presence of NADPH. In C and
D, fenthion sulfoxide was incubated with liver cytosol in the presence of 2-hydroxypyrimidine. The extract
of the incubation mixture was subjected to the assay. Each value represents the mean ± SD of four inde-
pendent experiments. 
*p < 0.05 and **p < 0.01 indicate signiﬁcant differences from control experiments to which only DHT was added.
Figure 4. Metabolism of fenthion or fenthion sulfox-
ide by rat liver preparations. (A) Oxidase activity of
rat liver microsomes toward fenthion in the pres-
ence of NADPH. (B) Reductase activity of rat liver
cytosol toward fenthion sulfoxide in the presence
of 2-hydroxypyrimidine. A mixture containing 0.1
µmol of fenthion or fenthion sulfoxide, 0.5 µmol of
an electron donor and liver preparation in 0.1 M
phosphate buffer (pH 7.4) was incubated at 37°C
for 30 min. Inhibitors were added at the concentra-
tion of 10–4 M. The fenthion sulfoxide or fenthion
formed was determined using HPLC as described
in Materials and Methods. Each value represents
the mean ± SD of four rats. 
*p < 0.05 and **p < 0.01 indicate signiﬁcant differences from
control experiments to which an electron donor was added.the weights of the prostate and seminal vesi-
cles, and these increases were completely
blocked by flutamide administration.
Fenthion also significantly suppressed the
effect of testosterone on the weight of both
glands (Figure 5). Thus, the antiandrogenic
effect of fenthion was also observed in vivo.
Discussion
In this study we examined the endocrine-
disrupting action of fenthion and its metabo-
lites, focusing on antiandrogenic and estrogenic
actions. No estrogenic or antiestrogenic activity
of fenthion was detected using estrogen-respon-
sive reporter assay. However, we demonstrated
that fenthion is a potent antiandrogen, though
fenthion sulfoxide and fenthion sulfone lack
this activity. Antiandrogenic activity of fen-
thion using ARE-luciferase reporter assay in
NIH3T3 cells was comparable to that of the
reference antiandrogen, flutamide. The
Hershberger assay has been used to screen
chemicals for androgenic and antiandrogenic
activities in vivo. In the Hershberger assay
used in this study, fenthion could block
androgen-dependent tissue growth. Fenthion’s
effect on androgen-dependent tissue weights
was significant. The antiandrogenic activity
shown by the reporter assay in NIH3T3 cells
is supported by the result of this in vivo assay.
It is known that fenthion is accumulated in
the environment (Fukushima 1991; Lacorte et
al. 1997; Pereira and Hostettler 1993).
Fenthion and its metabolites were detected in
rice and olive oil at concentrations of about 10
and 1 ppm, respectively (Cabras et al. 1993;
Fukuda et al. 1962). These compounds were
also detected in river water near Osaka, Japan
at 20–70 ng/L (Yamaguchi and Fukushima
1994). The concentration detected in the
river water is three orders of magnitude lower
than the concentration of fenthion that causes
antiandrogenic activity. However, the concen-
trations detected in rice and olive oil are sufﬁ-
cient to exert antiandrogenic action. Fenthion
may accumulate to a level in the body suffi-
cient to cause antiandrogenic action. Further,
fenthion in combination with other pesticides
may exhibit antiandrogenic activity. Lacorte et
al. (1997) reported that fenthion was oxidized
to the sulfoxide in the environment. This con-
version would contribute to the inactivation of
fenthion in terms of antiandrogenic action.
However, the effect of fenthion on reproduc-
tive tissues in rats in vivo shown in this study
cannot be neglected.
In this study, we demonstrated that 
fenitrothion and EPN, in addition to fenthion,
are antiandrogenic, but fensulfothion, trichlor-
fon, and malathion are not. Antiandrogenic
compounds so far reported include vinclozolin,
linuron, iprodione, chlozolinate, procymidone,
ﬂutamide, p,p´-DDE, and ketoconazole (Gray
et al. 1999a, 1999b; Lambright et al. 2000;
McIntyre et al. 2000; Ostby et al. 1999; You 
et al. 1999). In contrast, both positive and neg-
ative results on the antiandrogenic activity of
fenitrothion, a relative of fenthion, have been
reported (Ashby and Lefevre 2000; Curtis
2001; Sohoni et al. 2001; Sunami et al. 2000;
Tamura et al. 2001). The signiﬁcant antiandro-
genic activity of fenitrothion found in our study
supports previous ﬁndings that fenitrothion has
antiandrogenic properties. The structures of
fenthion and fenitrothion are the same except
for their para substituents. These structures
closely resemble that of ﬂutamide. It is difﬁcult
to understand the structural differences
between antiandrogenic and non-antiandro-
genic organophosphorus insecticides. Further
study of the structure requirements for, and the
mechanism of action of, antiandrogenic activity
of organophosphorus insecticides is needed.
Several reports have indicated that sulﬁde
compounds are metabolized mainly by oxida-
tion to the corresponding sulfoxide and sul-
fone compounds, and some sulfoxide
compounds are reduced in the sulfide com-
pounds in mammalian species (Benoit et al.
1992; DeBaun and Menn 1976; McLane 
et al. 1983; Mitchell and Waring 1986;
Tatsumi et al. 1983). However, the metabo-
lism of fenthion and fenthion sulfoxide has
not been extensively examined in mammalian
species.Brady and Arthur (1961) briefly
reported that fenthion was transformed to the
oxidized metabolites in rats in vivo. In the
current study, we showed that fenthion was
oxidized to fenthion sulfoxide, and the sulfox-
ide was reduced back to the parent fenthion.
However, fenthion sulfone was not formed
from fenthion in rat liver. We also demon-
strated the inactivation of the antiandrogenic
activity of fenthion upon metabolic oxidation
and the activation of fenthion sulfoxide by
reductive metabolism, and we suggest that the
interconversion between fenthion and fen-
thion sulfoxide in the body functions to
maintain antiandrogenic activity (Figure 6). 
Fenthion was oxidized to fenthion sulfoxide
by rat liver microsomes. The oxidizing activity
to the sulfoxide appears to be exhibited by both
CYP and FMO in rats. In our preliminary
study, microsomal preparations from cells
expressing recombinant human CYP 1A1, 1A2,
2B6, 2C9, and 3A4 and FMO I expressed in a
human B lymphoblastoid cell line, exhibited
sulfoxide oxidase activities toward fenthion
amounting to 3.6, 0.4, 0.4, 0.3, 1.0, and 62.4
nmol/min/mg protein, respectively. In contrast,
the reductive metabolism of fenthion sulfoxide
was catalyzed by a cytosolic enzyme, aldehyde
oxidase but not CYP. The velocity of this
reverse reaction is about the same as that of fen-
thion oxidation (1.1 and 0.8 nmol/min/mg
protein, respectively).
Metabolic modification of the activity of
endocrine disrupters is an important factor
inﬂuencing the toxicity of these compounds.
For example, vinclozolin, an antifungal agent,
was activated to antiandrogenic compounds by
hydrolysis of the amide linkage in animals
(Kelce et al. 1994). p,p´-DDT is metabolized
to p,p´-DDD and p,p´-DDE by reductive
dechlorination and dehydrochlorination,
respectively (Esaac and Matsumura 1980;
Kitamura et al. 2002). p,p´-DDD shows estro-
genic activity and p,p´-DDE shows antiandro-
genic activity (Chen et al. 1997; Kelce et al.
1995). Polychlorinated biphenyls are converted
to hydroxylated metabolites in animals, and
some hydroxylated polychlorinated biphenyls
show estrogenic and/or antithyroid hormonal
activity (Connor et al. 1997; Garner et al.
1999; Korach et al. 1988). Further, methoxy-
chlor, trans-stilbene, benzophenone, and
benzo[a]pyrene are proestrogens that require
metabolic activation by liver microsomal
mixed-function oxidase in animals (Charles
et al. 2000; Fertuck et al. 2001; Gaido et al.
1999; Nakagawa and Suzuki 2002; Sugihara et
al. 2000). In contrast, the estrogen screening
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Figure 5. The Hershberger assay of fenthion and
flutamide. Weights of the reproductive organs of
rats were expressed. T, testosterone propionate.
Castrated male F344 rats were treated with T (500
µg/kg/day) and/or fenthion (25 or 50 mg/kg/day) or
flutamide (6 mg/kg/day) for a week. One day after
the final administration, animals were sacrificed
and the prostate gland and seminal vesicle were
weighed. Each group consisted of seven rats,
except the control group with six animals. Each bar
indicates mean ± SD of six or seven rats. 
*p < 0.05 and **p < 0.01 indicate significant differences
from testosterone-dosed rats.
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Figure 6. Interconversion between fenthion and fenthion sulfoxide with rat liver preparations.test of fenthion and related compounds in this
study was negative, and these compounds were
not metabolically activated to estrogens (data
not shown). Much further work is needed to
examine the metabolic modiﬁcation of poten-
tially hazardous endocrine disrupters in
the environment.
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